Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297178269> ?p ?o ?g. }
- W4297178269 endingPage "106174" @default.
- W4297178269 startingPage "106174" @default.
- W4297178269 abstract "A series of novel nitric oxide (NO)-releasing 5,8-quinolinedione/furoxan hybrids (8a-h and 9a-h) were designed and synthesized through coupling different alkanolamine substituted phenylsulfonyl furoxan with 5,8-quinolinedione. Most compounds displayed high cytotoxic activity against drug-sensitive/-resistant cancer cells. In particular, the IC50 of 9a (0.42 µM) was about 9-fold lower than that of β-lap (3.69 µM) and 12-fold lower than that of SAHA (5.24 µM) in drug-resistant cancer cells. Also, 9a was demonstrated to selectively inhibit the growth of Bel7402/5-FU cancer cells. Mechanistic studies demonstrated that 9a could serve as an NO donor and nicotinamide quinone oxidoreductase 1 (NQO1) inhibitor (IC50 = 0.8 µM), which could induce the highest level of NO and reactive oxygen species (ROS) in Bel-7402/5-FU cancer cells. Furthermore, 9a could promote tumor cell apoptosis and autophagy via regulation of apoptosis-related protein (Bax, Bcl-2, and Caspase 3) and autophagy-associated proteins (LC3 and p62) in Bel-7402/5-FU cells. Taken together, 9a may be considered as a promising candidate for a further comprehensive study involving drug-resistant hepatocellular carcinoma." @default.
- W4297178269 created "2022-09-27" @default.
- W4297178269 creator A5000442440 @default.
- W4297178269 creator A5017000616 @default.
- W4297178269 creator A5021636467 @default.
- W4297178269 creator A5022345007 @default.
- W4297178269 creator A5026894671 @default.
- W4297178269 creator A5028473886 @default.
- W4297178269 creator A5034242696 @default.
- W4297178269 creator A5045341867 @default.
- W4297178269 creator A5061512296 @default.
- W4297178269 creator A5083202968 @default.
- W4297178269 date "2022-12-01" @default.
- W4297178269 modified "2023-10-16" @default.
- W4297178269 title "Development of novel nitric oxide-releasing quinolinedione/furoxan hybrids as NQO1 inhibitors for intervention of drug-resistant hepatocellular cancer" @default.
- W4297178269 cites W1147349766 @default.
- W4297178269 cites W2005628980 @default.
- W4297178269 cites W2049811880 @default.
- W4297178269 cites W2081583262 @default.
- W4297178269 cites W2196668263 @default.
- W4297178269 cites W2317437140 @default.
- W4297178269 cites W2328864894 @default.
- W4297178269 cites W2333560586 @default.
- W4297178269 cites W2346294227 @default.
- W4297178269 cites W2473712600 @default.
- W4297178269 cites W2552325207 @default.
- W4297178269 cites W2583659675 @default.
- W4297178269 cites W2615885638 @default.
- W4297178269 cites W2620887170 @default.
- W4297178269 cites W2725933288 @default.
- W4297178269 cites W2739525201 @default.
- W4297178269 cites W2755710985 @default.
- W4297178269 cites W2781525129 @default.
- W4297178269 cites W2792277808 @default.
- W4297178269 cites W2804161626 @default.
- W4297178269 cites W2856225947 @default.
- W4297178269 cites W2889227864 @default.
- W4297178269 cites W2900447455 @default.
- W4297178269 cites W2902945583 @default.
- W4297178269 cites W2905092601 @default.
- W4297178269 cites W2909437688 @default.
- W4297178269 cites W2945783324 @default.
- W4297178269 cites W2974723866 @default.
- W4297178269 cites W2982161529 @default.
- W4297178269 cites W2982475198 @default.
- W4297178269 cites W2990323558 @default.
- W4297178269 cites W2990361782 @default.
- W4297178269 cites W2995553925 @default.
- W4297178269 cites W2995980623 @default.
- W4297178269 cites W3016510566 @default.
- W4297178269 cites W3017676418 @default.
- W4297178269 cites W3049928016 @default.
- W4297178269 cites W3092226428 @default.
- W4297178269 cites W3108332964 @default.
- W4297178269 cites W3116446716 @default.
- W4297178269 cites W4210821109 @default.
- W4297178269 cites W4220722398 @default.
- W4297178269 cites W4282013086 @default.
- W4297178269 cites W4283455030 @default.
- W4297178269 doi "https://doi.org/10.1016/j.bioorg.2022.106174" @default.
- W4297178269 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36191428" @default.
- W4297178269 hasPublicationYear "2022" @default.
- W4297178269 type Work @default.
- W4297178269 citedByCount "2" @default.
- W4297178269 countsByYear W42971782692023 @default.
- W4297178269 crossrefType "journal-article" @default.
- W4297178269 hasAuthorship W4297178269A5000442440 @default.
- W4297178269 hasAuthorship W4297178269A5017000616 @default.
- W4297178269 hasAuthorship W4297178269A5021636467 @default.
- W4297178269 hasAuthorship W4297178269A5022345007 @default.
- W4297178269 hasAuthorship W4297178269A5026894671 @default.
- W4297178269 hasAuthorship W4297178269A5028473886 @default.
- W4297178269 hasAuthorship W4297178269A5034242696 @default.
- W4297178269 hasAuthorship W4297178269A5045341867 @default.
- W4297178269 hasAuthorship W4297178269A5061512296 @default.
- W4297178269 hasAuthorship W4297178269A5083202968 @default.
- W4297178269 hasConcept C121608353 @default.
- W4297178269 hasConcept C154317977 @default.
- W4297178269 hasConcept C178790620 @default.
- W4297178269 hasConcept C185592680 @default.
- W4297178269 hasConcept C190283241 @default.
- W4297178269 hasConcept C202751555 @default.
- W4297178269 hasConcept C203522944 @default.
- W4297178269 hasConcept C2776948483 @default.
- W4297178269 hasConcept C48349386 @default.
- W4297178269 hasConcept C502942594 @default.
- W4297178269 hasConcept C519581460 @default.
- W4297178269 hasConcept C54355233 @default.
- W4297178269 hasConcept C55493867 @default.
- W4297178269 hasConcept C86803240 @default.
- W4297178269 hasConcept C96232424 @default.
- W4297178269 hasConcept C98274493 @default.
- W4297178269 hasConceptScore W4297178269C121608353 @default.
- W4297178269 hasConceptScore W4297178269C154317977 @default.
- W4297178269 hasConceptScore W4297178269C178790620 @default.
- W4297178269 hasConceptScore W4297178269C185592680 @default.
- W4297178269 hasConceptScore W4297178269C190283241 @default.
- W4297178269 hasConceptScore W4297178269C202751555 @default.